Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CRON.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 370.73M
March 31, 2026 376.26M
December 31, 2025 381.59M
September 30, 2025 382.89M
June 30, 2025 383.81M
March 31, 2025 385.41M
December 31, 2024 382.53M
September 30, 2024 382.29M
June 30, 2024 382.28M
March 31, 2024 382.01M
December 31, 2023 381.30M
September 30, 2023 381.11M
June 30, 2023 381.09M
March 31, 2023 380.82M
December 31, 2022 380.58M
September 30, 2022 378.35M
June 30, 2022 377.90M
March 31, 2022 375.30M
December 31, 2021 374.95M
September 30, 2021 373.30M
June 30, 2021 371.81M
March 31, 2021 371.66M
December 31, 2020 360.25M
September 30, 2020 355.73M
Date Value
June 30, 2020 349.89M
March 31, 2020 348.82M
December 31, 2019 348.82M
September 30, 2019 343.76M
June 30, 2019 336.14M
March 31, 2019 333.02M
December 31, 2018 178.72M
September 30, 2018 178.70M
June 30, 2018 176.91M
March 31, 2018 161.63M
December 31, 2017 149.36M
September 30, 2017 142.65M
June 30, 2017 133.14M
March 31, 2017 131.48M
December 31, 2016 121.73M
September 30, 2016 115.05M
June 30, 2016 75.05M
March 31, 2016 42.62M
December 31, 2015 42.62M
September 30, 2015 34.61M
June 30, 2015 35.04M
March 31, 2015 34.79M
June 30, 2014 0.7081M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Lexaria Bioscience Corp. 1.652M
Target Group, Inc. (Canada) 617.03M
Tilray Brands, Inc. 131.09M
InMed Pharmaceuticals, Inc. 5.339M
XORTX Therapeutics, Inc. 1.731M